These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 16253562)

  • 61. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
    Tripathy S; Anand A; Inamdar V; Manoj MM; Khillare KM; Datye AS; Iyer R; Kanoj DM; Thakar M; Kale V; Pereira M; Risbud AR
    Indian J Med Res; 2011 May; 133(5):521-8. PubMed ID: 21623038
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TB situation in Albania, 2001-2008.
    Hafizi H; Tafaj S; Bardhi D; Dilko E; Aliko A
    Pneumologia; 2009; 58(2):104-7. PubMed ID: 19637762
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Revised National Tuberculosis Control Programme (RNTCP).
    Muruganathan A; Thomas A; Muniyandi M; Chandrasekaran V
    J Indian Med Assoc; 2010 Dec; 108(12):868-70. PubMed ID: 21661468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. National Tuberculosis Control Programme.
    Uke BT
    Health Millions; 1995; 21(1):14-6. PubMed ID: 12288988
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project.
    Netto EM; Dye C; Raviglione MC
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):310-20. PubMed ID: 10206501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TB control in India--efforts, challenges and priorities.
    Sisodia RS; Jain DK; Agarwal SS; Gupta A
    J Indian Med Assoc; 2011 Dec; 109(12):921-4, 928. PubMed ID: 23469576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003.
    Sisodia RS; Wares DF; Sahu S; Chauhan LS; Zignol M
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1373-9. PubMed ID: 17167955
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Public-private partnership in tuberculosis control: experience in Hyderabad, India.
    Murthy KJ; Frieden TR; Yazdani A; Hreshikesh P
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):354-9. PubMed ID: 11334254
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center.
    Muniyandi M; Ramachandran R; Balasubramanian R; Narayanan PR
    J Commun Dis; 2006 Mar; 38(3):204-15. PubMed ID: 17373353
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DOTS implementation in a middle-income country: development and evaluation of a novel approach.
    Vaca J; Peralta H; Gresely L; Cordova R; Kuffo D; Romero E; Tannenbaum TN; Houston S; Graham B; Hernandez L; Menzies D
    Int J Tuberc Lung Dis; 2005 May; 9(5):521-7. PubMed ID: 15875923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India.
    Subramani R; Radhakrishna S; Frieden TR; Kolappan C; Gopi PG; Santha T; Wares F; Selvakumar N; Narayanan PR
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):916-20. PubMed ID: 18647451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A rural public-private partnership model in tuberculosis control in south India.
    Balasubramanian R; Rajeswari R; Vijayabhaskara RD; Jaggarajamma K; Gopi PG; Chandrasekaran V; Narayanan PR
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1380-5. PubMed ID: 17167956
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals.
    Ramon-Pardo P; Del Granado M; Gerger A; Canela Soler J; Mir M; Armengol R; Lopez Olarte RA; Rodriguez R
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):969-75. PubMed ID: 19723376
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of treatment outcome in re-treatment versus new smear positive cases of tuberculosis under RNTCP.
    Pardeshi GS; Deshmukh D
    Indian J Public Health; 2007; 51(4):237-9. PubMed ID: 18232166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India.
    Ambe G; Lönnroth K; Dholakia Y; Copreaux J; Zignol M; Borremans N; Uplekar M
    Int J Tuberc Lung Dis; 2005 May; 9(5):562-8. PubMed ID: 15875930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Working towards TB elimination the WHO Regional Strategic Plan (2006-2015).
    Nair N; Cooreman E
    J Commun Dis; 2006 Mar; 38(3):185-90. PubMed ID: 17373351
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Private-public mix: a prioritisation under RNTCP--an Indian perspective.
    Arora VK; Gupta R
    Indian J Chest Dis Allied Sci; 2004; 46(1):27-37. PubMed ID: 14870866
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scientific basis of directly observed treatment, short-course (DOTS).
    Sharma SK; Mohan A
    J Indian Med Assoc; 2003 Mar; 101(3):157-8, 166. PubMed ID: 14603962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.